dr mark hyman glp 1 How to Improve Your Vitality & Heal From Disease | Dr. - Huberman Lab Ozempic and other GLP1 drugs
Description
SURMOUNT-2 focused on participants with obesity and type 2 diabetes
An important societal question is access equity
An obesity-associated gut microbiome with increased capacity for energy harvest
Impaired secretion of GLP-1 can contribute to type 2 diabetes
Novo Nordisk also has a lower market capitalization and valuation relative to Eli Lilly.
Compounded semaglutide is not FDA-approved and may vary in quality between suppliers
